scispace - formally typeset
Open AccessJournal ArticleDOI

Traditional Tibetan medicine in China: A systematic overview of randomized clinical trials

Reads0
Chats0
TLDR
Clinical research in TTM in China shows that TTM might have potential benefit for the management of many diseases and more efforts should be made to improve the quality of RCTs in China and support TTM's further clinical applications.
About
This article is published in European Journal of Integrative Medicine.The article was published on 2015-10-01 and is currently open access. It has received 19 citations till now. The article focuses on the topics: Randomized controlled trial & Cochrane Library.

read more

Citations
More filters
Journal ArticleDOI

Natural Medicines Used in the Traditional Tibetan Medical System for the Treatment of Liver Diseases.

TL;DR: The present paper summarized the natural Tibetan medicines that have been used in Tibetan traditional system of medicine to treat liver diseases by bibliographic investigation of 22 Tibetan medicine monographs and drug standards.
Journal ArticleDOI

Below the radar innovations and emerging property right approaches in Tibetan medicine.

TL;DR: It is argued that beyond the usual complex medical science and technology led—innovations, the pathways of cumulative processes and creative additions through informal experiential learning platforms, where the transfers of knowledge become part of livelihood and social benefits is ubiquitous in Tibetan medicine.
Journal ArticleDOI

Contested Issues of Efficacy and Safety between Transnational Formulation Regimes of Tibetan Medicines in China and Europe.

TL;DR: This paper conceptualises three distinct formulation regimes of Tibetan medicines, offering a heuristic model for transnational comparison-a classical, an industrialised or reformulated, and a polyherbal regime.
Journal ArticleDOI

SanWeiGanJiang San relieves liver injury via Nrf2/Bach1.

TL;DR: In CCl4-induced chronic liver injury in rats, SWGJS repaired the liver structure in the early stages of liver damage as evidenced by reduced ALT and AST in the serum, increased GSH-Px activity and decreased MDA levels in the liver over time.
References
More filters
Journal ArticleDOI

CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials

TL;DR: This update of the CONSORT statement improves the wording and clarity of the previous checklist and incorporates recommendations related to topics that have only recently received recognition, such as selective outcome reporting bias.
Journal ArticleDOI

Randomized trials published in some Chinese journals: how many are randomized?

TL;DR: Most reports of randomized controlled Trials published in some Chinese journals were not real randomized controlled trials owing to a lack of adequate understanding on the part of the authors of rigorous clinical trial design and a good practice guide for peer review needs to be developed.
Journal ArticleDOI

The health transition, global modernity and the crisis of traditional medicine: the Tibetan case

TL;DR: Analyzing the case of Tibetan medicine and other Asian medical systems, it is shown how the inevitable slide into narrow herbal traditions and a loss of those elements of diagnosis and therapy which may be the most valuable and effective occurs.
Journal ArticleDOI

Evidence-based medicine in China

TL;DR: The health-care system in China is yet to be improved, and the World Health Organization (WHO) Report ranked China 144th place out of 191 member countries for the overall health services.
Related Papers (5)